Growth Metrics

Teladoc Health (TDOC) Cost Of Revenue (2014 - 2026)

Teladoc Health recorded quarterly Cost of Revenue of $51.3 million in Q1 2026, down 73.98% quarter-over-quarter from $197.0 million in Q4 2025, and down 73.95% year-over-year from $196.8 million in Q1 2025.

Teladoc Health's Cost of Revenue history runs 13 years deep, the most recent figure standing at $51.3 million for Q1 2026.

  • In Q1 2026, Cost of Revenue fell 73.95% year-over-year to $51.3 million; the TTM figure through Mar 2026 stood at $626.0 million (down 46.2% YoY), while the FY2025 annual figure was $771.6 million, up 2.71% from the prior year.
  • Cost of Revenue came in at $51.3 million for Q1 2026 at Teladoc Health, down from $197.0 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $599.7 million in Q4 2023 to a low of -$327.9 million in Q4 2022.
  • A 5-year average of $151.5 million and a median of $179.7 million in 2024 frame the typical range for Cost of Revenue.
  • Across the five-year window, Cost of Revenue slumped 171.45% in 2022 and surged 282.87% in 2023, its largest moves.
  • Teladoc Health's Cost of Revenue stood at -$327.9 million in 2022, then soared by 282.87% to $599.7 million in 2023, then retreated by 0.12% to $599.0 million in 2024, then slumped by 67.1% to $197.0 million in 2025, then tumbled by 73.98% to $51.3 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $51.3 million, $197.0 million, and $187.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.